XML 21 R6.htm IDEA: XBRL DOCUMENT v3.7.0.1
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 3 Months Ended
Jul. 01, 2017
Jul. 02, 2016
Cash flows from operating activities:    
Net income (loss) $ 59.5 $ (22.3)
Adjustments to reconcile net income (loss) to net cash provided by operating activities:    
Depreciation and amortization expense 72.9 78.4
Deferred income tax expense (benefit) (14.7) 3.0
Equity in losses of equity-method investees 0.9 1.9
Non-cash stock-based compensation expense 21.6 17.7
Non-cash impairment of assets 9.7 19.4
Non-cash restructuring-related inventory charges 0.7 54.0
Other non-cash charges 1.1 9.7
Changes in operating assets and liabilities:    
Accounts receivable 174.0 174.4
Inventories (55.4) (167.8)
Prepaid expenses and other current assets (4.6) (23.2)
Accounts payable and accrued liabilities 42.4 141.7
Income tax receivables and payables 8.7 (20.8)
Deferred income 0.6 (2.3)
Other balance sheet changes 16.8 (20.9)
Net cash provided by operating activities 334.2 242.9
Cash flows from investing activities:    
Capital expenditures (41.9) (77.6)
Purchases of investments (270.4) (144.5)
Proceeds from sales and maturities of investments 187.4 182.2
Acquisitions and ventures (3.6) (1.3)
Net cash used in investing activities (128.5) (41.2)
Cash flows from financing activities:    
Proceeds from issuance of short-term debt 0.0 943.9
Repayments of short-term debt 0.0 (970.0)
Payments of capital lease obligations (6.2) (7.2)
Payments of dividends (40.5) (41.4)
Repurchases of common stock, including shares surrendered for tax withholdings (14.4) (114.9)
Proceeds from exercises of stock options 0.1 3.2
Net cash used in financing activities (61.0) (186.4)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash 19.9 (14.6)
Net increase in cash, cash equivalents, and restricted cash 164.6 0.7
Cash, cash equivalents, and restricted cash at beginning of period 711.8 502.1
Cash, cash equivalents, and restricted cash at end of period $ 876.4 $ 502.8